RNS Number:6922R
Phorm Inc
04 April 2008
This release replaces RNS no 6514R released today. The full announcement appears
below and all material details remain unchanged
Phorm, Inc. ('Phorm' or the 'Company')
Notification of Shareholding
Phorm, Inc. (AIM: PHRM and PHRX) received notification on 2 April 2008 that on
27 March 2008, as a result of changes to Phorm's issued share capital, Majedie
Investments Plc holds a total of 539,555 common shares which now represents
approximately 3.9% of the issued share capital of the Company.
As at 4 April 2008, the Company had 13,831,224 common shares with a nominal
value of US$0.001 per share with voting rights in issue, none of which are held
in treasury.
Enquiries:
Kent Ertugrul (Chairman & Chief Executive) +44 20 7638 9571
Lynne Millar (Chief Financial Officer)
Citigate Dewe Rogerson +44 20 7638 9571
Simon Rigby
Justin Griffiths
Canaccord Adams Limited +44 20 7050 6500
(Nominated Adviser)
Mark Williams
Andrew Chubb
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGGDVDNGRZM
|